BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9101 related articles for article (PubMed ID: 17668534)

  • 21. Multidisciplinary treatment of primary melanoma.
    Yao K; Balch G; Winchester DJ
    Surg Clin North Am; 2009 Feb; 89(1):267-81, xi. PubMed ID: 19186240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant therapy of melanoma.
    Spitler LE
    Oncology (Williston Park); 2002 Jan; 16(1 Suppl 1):40-8. PubMed ID: 11829281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinoma.
    Atkins MB; Regan M; McDermott D
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6342S-6S. PubMed ID: 15448028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant interferon therapy for melanoma.
    Hancock B; Wheatley K; Ives N; Gore M
    J Clin Oncol; 2005 Apr; 23(10):2431; author reply 2431-2. PubMed ID: 15800339
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of surgery in treatment of stage IV melanoma.
    Young SE; Martinez SR; Essner R
    J Surg Oncol; 2006 Sep; 94(4):344-51. PubMed ID: 16917867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-institution outcome of high-dose interleukin-2 (HD IL-2) therapy for metastatic melanoma and analysis of favorable response in brain metastases.
    Powell S; Dudek AZ
    Anticancer Res; 2009 Oct; 29(10):4189-93. PubMed ID: 19846971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of malignant melanoma with interleukin-2.
    Philip PA; Flaherty L
    Semin Oncol; 1997 Feb; 24(1 Suppl 4):S32-8. PubMed ID: 9122732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoimmune antibodies and recurrence-free interval in melanoma patients treated with adjuvant interferon.
    Bouwhuis MG; Suciu S; Collette S; Aamdal S; Kruit WH; Bastholt L; Stierner U; Salès F; Patel P; Punt CJ; Hernberg M; Spatz A; ten Hagen TL; Hansson J; Eggermont AM;
    J Natl Cancer Inst; 2009 Jun; 101(12):869-77. PubMed ID: 19509353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninterferon-based adjuvant therapy for high-risk melanoma.
    Spitler LE
    Expert Rev Anticancer Ther; 2002 Oct; 2(5):547-62. PubMed ID: 12382523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized adjuvant therapy trials in melanoma: surgical and systemic.
    Eggermont AM; Gore M
    Semin Oncol; 2007 Dec; 34(6):509-15. PubMed ID: 18083374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cutaneous melanoma].
    Eigentler TK; Mügge LO; Bembenek A; Garbe C
    Hautarzt; 2007 Oct; 58(10):885-97; quiz 898. PubMed ID: 17973138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifungal immunity and adjuvant cytokine immune enhancement in cancer patients with invasive fungal infections.
    Safdar A
    Clin Microbiol Infect; 2007 Jan; 13(1):1-4. PubMed ID: 17184281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colony-stimulating factor or interleukin-2: the transgene determines the composition of the inflammatory infiltrate.
    Hofbauer GF; Baur T; Bonnet MC; Tartour E; Burg G; Berinstein NL; Dummer R
    Melanoma Res; 2008 Apr; 18(2):104-11. PubMed ID: 18337646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cytokines: current status and prospects in the treatment of skin tumors].
    Nashan D; Luger TA
    Hautarzt; 2001 Aug; 52(8):691-6. PubMed ID: 11544938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melanoma vaccines.
    Naylor MF
    Dermatol Online J; 2000 Sep; 6(1):5. PubMed ID: 11328615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Adjuvant interferon treatment of melanoma].
    Török L
    Magy Onkol; 2003; 47(1):105-7. PubMed ID: 12704462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolated limb infusion as palliative treatment for advanced limb disease in patients with AJCC stage IV melanoma.
    Kroon HM; Lin DY; Kam PC; Thompson JF
    Ann Surg Oncol; 2009 May; 16(5):1193-201. PubMed ID: 19224288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant therapy of melanoma.
    Shah GD; Chapman PB
    Cancer J; 2007; 13(3):217-22. PubMed ID: 17620773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic therapy of disseminated malignant melanoma: an evidence-based overview of the state-of-the-art in daily routine.
    Nashan D; Müller ML; Grabbe S; Wustlich S; Enk A
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1305-18. PubMed ID: 17958834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Adjuvant chemotherapy as a component of complex treatment for skin melanoma].
    Kudriavtsev DV; Kudriavtseva GT; Mardynskiĭ IuS
    Vopr Onkol; 2008; 54(2):170-7. PubMed ID: 18522165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 456.